TARGETED CLINICAL RESEARCH TO ADDRESS SELECT VIRAL INFECTIONS
$1,321,202N01FY2018AINIH
Fred Hutchinson Cancer Research Center, Seattle WA
Investigators
Abstract
To advance the development of therapeutic strategies for rare and/or emerging viral diseases of medical importance in targeted patient populations by 1) characterizing contemporary course of the clinical disease, and/or 2) directly evaluating a therapy. This study is conducted in adult transplant patients.
View original record on NIH RePORTER →